Why the study?
Does an implantable cardioverter-defibrillator improve overall survival in survivors of ventricular fibrillation or sustained ventricular tachycardia compared to antiarrhythmic drugs?
Does an implantable cardioverter-defibrillator improve overall survival in survivors of ventricular fibrillation or sustained ventricular tachycardia compared to antiarrhythmic drugs?
Implantable cardioverter-defibrillators are superior to antiarrhythmic drugs for increasing overall survival in patients resuscitated from near-fatal ventricular arrhythmias.
Among survivors of ventricular fibrillation or sustained ventricular tachycardia causing severe symptoms, the implantable cardioverter-defibrillator is superior to antiarrhythmic drugs for increasing overall survival.
No takes yet. Share an insight, caveat, or question.
The Antiarrhythmics versus Implantable Defibrillators Investigators (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: